Tech Company Financing Transactions
Osprey Pharmaceuticals Funding Round
Osprey Pharmaceuticals, operating out of San Francisco, secured $11 million from Burrill & Company, BDC Venture Capital and GeneChem.
Transaction Overview
Burrill & Company (Lead Investor) (John Hamer)
BDC Venture Capital (Jean-Francois Pariseau)
GeneChem (Martial Lacroix)
Company Information
San Francisco, CA 94104
USA
Management Team
Browse more venture capital transactions:
Prev: 9/3/2008: Old Road Computing venture capital transaction
Next: 9/4/2008: Histogen venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on funding rounds that are announced publicly. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs